Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Salarius Pharmaceuticals Inc
(NQ:
SLRX
)
1.860
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Salarius Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
July 02, 2021
Gainers Odonate Therapeutics (NASDAQ:ODT)...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 01, 2021
Gainers Alterity Therapeutics (NASDAQ:ATHE
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 18, 2021
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) stock rose 21.47% to $5.26 during Friday's pre-market session. The company's market cap stands at $68.5 million....
Via
Benzinga
Salarius Pharmaceuticals Launches Mid-Stage Blood Cancer Trial With Seclidemstat
June 15, 2021
Salarius Pharmaceuticals Inc (NASDAQ: SLRX) has initiated an investigator-initiated Phase 1/2 trial to investigate seclidemstat as a potential treatment for...
Via
Benzinga
Salarius' Seclidemstat Shows Single-Agent Drug Activity in Heavily Pre-Treated Sarcomas Patients
June 07, 2021
Salarius Pharmaceuticals Inc (NASDAQ: SLRX) presented data at the American Society of Clinical Oncology Virtual Annual Meeting for seclidemstat, a reversible...
Via
Benzinga
64 Biggest Movers From Friday
June 07, 2021
Gainers Senseonics Holdings, Inc. (NYSE: SENS) jumped 42% to settle at $2.91 on Friday after the company disclosed results from a PROMISE study evaluating its Eversense CGM...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 04, 2021
Gainers Windtree Therapeutics (NASDAQ:WINT) shares rose 35.85% to $2.69 during Friday's regular session. Trading volume for this security as of 12:30 EST is 117.5...
Via
Benzinga
40 Stocks Moving In Friday's Mid-Day Session
June 04, 2021
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares jumped 68.8% to $25.49 after gaining 23% on Thursday. Senseonics Holdings, Inc. (NYSE: SENS) gained 26% to $2.5817 after the...
Via
Benzinga
24 Stocks Moving in Friday's Pre-Market Session
June 04, 2021
Gainers Senseonics Holdings, Inc. (NYSE: SENS) rose 37.1% to $2.81 in pre-market trading after the company disclosed results from a PROMISE study evaluating its Eversense CGM...
Via
Benzinga
55 Biggest Movers From Yesterday
June 04, 2021
Gainers DLocal Limited (NASDAQ: DLO) shares jumped 54.2% to close at $32.39 on Thursday. DLocal raised around $92.6 million from the sale of 4.4 million shares in its IPO. GTT...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
46 Stocks Moving In Thursday's Mid-Day Session
June 03, 2021
Gainers GTT Communications, Inc. (NYSE: GTT) shares jumped 66% to $4.16 on abnormally-high volume. The company’s stock also jumped over 57% on Wednesday. Ra Medical Systems...
Via
Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
June 03, 2021
Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14...
Via
Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
Looking Into Salarius Pharmaceuticals's Return On Capital Employed
May 27, 2021
In Q1, Salarius Pharmaceuticals (NASDAQ:SLRX) posted sales of $1.27 million. Earnings were up 2.69%, but Salarius Pharmaceuticals still reported an overall loss of $1.80 million....
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 24, 2021
Gainers Strongbridge Biopharma (NASDAQ:SBBP) stock moved upwards by 14.1% to $2.75 during Monday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 21, 2021
Gainers Sio Gene Therapies (NASDAQ:SIOX) ...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 14, 2021
Gainers Evaxion Biotech (NASDAQ:EVAX) sha...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 12, 2021
Gainers Celyad Oncology (NASDAQ:CYAD) sto...
Via
Benzinga
Salarius Pharmaceuticals: Q1 Earnings Insights
May 12, 2021
Shares of Salarius Pharmaceuticals (NASDAQ:SLRX) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 72.73% year over...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 13, 2021
Gainers NovoCure (NASDAQ:NVCR) shares rose 63.02% to $215.0 during Tuesday's pre-market session. The company's market cap stands at $22.0 billion. Axcella Health (...
Via
Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For May 12, 2021
May 12, 2021
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report...
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.